US pharma firm Gilead Sciences likely to introducing anti-viral drug remdesivir in India

Credit: pixabay.com

Officials of the Union Health Ministry, along with the DCGI held a discussion with the representatives of Gilead Sciences on Wednesday to prepare a road map for introducing remdesivir in India.

US pharmaceutical giant Gilead Sciences is likely to apply to India’s Central Drugs Standard Control Organisation (CDSCO) soon seeking marketing authorisation for its anti-viral drug remdesivir, which is being considered by many as a potential medication for Covid-19.

Officials of the Union Health Ministry, along with the Drugs Controller General of India (DCGI) held a discussion with the representatives of Gilead Sciences on Wednesday to prepare a road map for introducing remdesivir in India, sources said. “The US-based company is keen on applying for granting of marketing authorization for its drug remdesivir in India. They were apprised about the regulatory procedures for granting of approval to a new drug in the country and were assured of total facilitation. “The company representatives said they will get back after discussion with their board of directors,” an official said.

Source: hindustantimes

Current Issue

NEWSLETTER